ARDS - Aridis Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
No. of analysts0031
Avg. Estimate00-0.810.26
Low estimate00-1.520.26
High estimate000.440.26
Year ago EPS-0.44-0.45-1.62-0.81
Revenue estimateCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
No. of analysts0031
Avg. EstimateN/AN/A25.5M41.41M
Low estimateN/AN/AN/A41.41M
High estimateN/AN/A75M41.41M
Year ago salesN/AN/A3.09M25.5M
Sales growth (year/est)N/AN/A725.00%62.40%
Earnings history30/03/202229/06/202229/09/202230/12/2022
Est. EPS-0.51-0.06-0.17-0.41
Actual EPS-0.44-0.45-0.47-0.6
Difference0.07-0.39-0.3-0.19
Surprise %13.70%-650.00%-176.50%-46.30%
EPS trendCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
Current estimate00-0.810.26
7 days ago00-0.810.26
30 days ago00-0.810.26
60 days ago00-0.810.26
90 days ago00-0.810.26
EPS revisionsCurrent qtr. (Mar 2023)Next qtr. (Jun 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesARDSIndustrySector(s)S&P 500
Current qtr.N/AN/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current year50.00%N/AN/AN/A
Next year132.10%N/AN/AN/A
Next 5 years (per annum)59.10%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A